H-CYTE, Inc. – OTC:HCYT

H-CYTE stock price today

$2.21
+0.98
+79.67%
Financial Health
0
1
2
3
4
5
6
7
8
9

H-CYTE stock price monthly change

-57.73%
month

H-CYTE stock price quarterly change

-57.73%
quarter

H-CYTE stock price yearly change

+6065.41%
year

H-CYTE key metrics

Market Cap
 1.05M
Enterprise value
 6.20M
P/E
 -0.06
EV/Sales
 7.97
EV/EBITDA
 -0.67
Price/Sales
 0.80
Price/Book
 -0.07
PEG ratio
 N/A
EPS
 -23.86
Revenue
 N/A
EBITDA
 -2.38M
Income
 -9.09M
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 -1227.74%
Oper. margin
 -529.98%
Gross margin
 65.58%
EBIT margin
 -529.98%
EBITDA margin
 N/A

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

H-CYTE stock price history

H-CYTE stock forecast

H-CYTE financial statements

Profit Margin

H-CYTE, Inc. (OTC:HCYT): Profit margin
Sep 2022 0 -2.70M
Dec 2022 0 -2.28M
Mar 2023 0 -3.60M
Sep 2023 0 -495.77K
HCYT income statement history
0%
Yield TTM
H-CYTE, Inc. (OTC:HCYT): Payout ratio
Payout ratio 0%
H-CYTE, Inc. (OTC:HCYT): Dividend Yield
2018
2019 0.12%
2020
2021
2022
HCYT dividends history

Debt to Assets

H-CYTE, Inc. (OTC:HCYT): Debt to assets
Sep 2022 240559 8.39M 3487.72%
Dec 2022 137357 9.49M 6912.46%
Mar 2023 349355 11.67M 3342.68%
Sep 2023 789316 11.67M 1479.62%
HCYT balance sheet history

Cash Flow

H-CYTE, Inc. (OTC:HCYT): Cash Flow
Jun 2022 -643.12K 0 347.71K
Sep 2022 -294.62K 469 285.00K
Dec 2022 -91.73K -469 55.01K
Mar 2023 -361.99K 0 478.00K
HCYT cash flow history

H-CYTE alternative data

H-CYTE
Employees

H-CYTE, Inc. (OTC:HCYT): Employee count
Aug 2023 2
Sep 2023 2
Oct 2023 2
Nov 2023 2
Dec 2023 2
Jan 2024 2
Feb 2024 2
Mar 2024 2
Apr 2024 2
May 2024 2
Jun 2024 2
Jul 2024 2

H-CYTE other data

H-CYTE
Insider Trading

H-CYTE, Inc. (OTC:HCYT): Insider trades (number of shares)
Period Buy Sel
Dec 2019 35000 0
Jan 2020 25000 0
Transaction Date Insider Security Shares Price per share Total value Source
Option
FARRIOR J REX III 10 percent owner
 STOCK PURCHASE WARRANTS 693,477 $0.01 $9,709
Option
FARRIOR J REX III 10 percent owner
 COMMON STOCK 693,477 $0.01 $9,709
Option
WAGNER TODD R 10 percent owner
 STOCK PURCHASE WARRANTS 41,608,884 $0.01 $582,524
Option
WAGNER TODD R 10 percent owner
 COMMON STOCK 41,608,884 $0.01 $582,524
Purchase
YURKOWSKY MICHAEL director
 Common Stock 8,100 $0.13 $1,045
Purchase
YURKOWSKY MICHAEL director
 Common Stock 5,000 $0.14 $675
Purchase
YURKOWSKY MICHAEL director
 Common Stock 1,900 $0.14 $257
Purchase
YURKOWSKY MICHAEL director
 Common Stock 10,000 $0.15 $1,450
Purchase
YURKOWSKY MICHAEL director
 Common Stock 7,500 N/A N/A
Purchase
YURKOWSKY MICHAEL director
 Common Stock 27,500 N/A N/A
HCYT insider trading transactions

H-CYTE
Executives

Insider Compensation
Mr. Robert Greif (1965) Pres
 $484,830
Mr. Jeremy Daniel (1976) Chief Financial Officer
 $200,000
Mr. Michael W. Yurkowsky (1974) Chief Executive Officer & Director
 $50,000

Frequently Asked Questions (FAQ)

  • What's the price of H-CYTE stock today?

    One share of H-CYTE stock can currently be purchased for approximately $2.21.

  • When is H-CYTE's next earnings date?

    Unfortunately, H-CYTE's (HCYT) next earnings date is currently unknown.

  • Does H-CYTE pay dividends?

    No, H-CYTE does not pay dividends.

  • How much money does H-CYTE make?

    H-CYTE has a market capitalization of 1.05M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 71.86% to 453.46K US dollars.

  • What is H-CYTE's stock symbol?

    H-CYTE, Inc. is traded on the OTC under the ticker symbol "HCYT".

  • What is H-CYTE's primary industry?

    Company operates in the Healthcare sector and Biotechnology industry.

  • How do i buy shares of H-CYTE?

    Shares of H-CYTE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • Who are H-CYTE's key executives?

    H-CYTE's management team includes the following people:

    • Mr. Robert Greif Pres(age: 60, pay: $484,830)
    • Mr. Jeremy Daniel Chief Financial Officer(age: 49, pay: $200,000)
    • Mr. Michael W. Yurkowsky Chief Executive Officer & Director(age: 51, pay: $50,000)

  • How many employees does H-CYTE have?

    As Jul 2024, H-CYTE employs 2 workers.

  • When H-CYTE went public?

    H-CYTE, Inc. is publicly traded company for more then 10 years since IPO on 2 Feb 2015.

  • What is H-CYTE's official website?

    The official website for H-CYTE is hcyte.com.

  • Where are H-CYTE's headquarters?

    H-CYTE is headquartered at 201 East Kennedy Boulevard, Tampa, FL.

  • How can i contact H-CYTE?

    H-CYTE's mailing address is 201 East Kennedy Boulevard, Tampa, FL and company can be reached via phone at +84 46336839.

H-CYTE company profile:

H-CYTE, Inc.

hcyte.com
Exchange:

OTC

Full time employees:

8

Industry:

Biotechnology

Sector:

Healthcare

H-CYTE, Inc., a biopharmaceutical company, develops and delivers various treatments for patients with chronic respiratory and pulmonary disorders in the United States. The company develops and implements treatment options in autologous cellular therapy to treat chronic lung disorders. It has a product supply agreement with Rion, LLC to develop and distribute a biologic for chronic obstructive pulmonary disease. The company is headquartered in Tampa, Florida.

+84 46336839
201 East Kennedy Boulevard
Tampa, FL 33607

CIK: 0001591165
ISIN: US4041241096
CUSIP: 404124109